Locations
London, UK · England, UK · Mile End, London, UK · Kingston Vale, London SW15, UK · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2017
Pear Bio is a Boston and London-based AI-enabled biotech company focused on delivering functional precision medicine tests and therapeutics for patients with hard-to-treat cancers. The company utilizes tumor biopsies to create 3D immune-microtumors, allowing for side-by-side testing of various treatment options to predict patient responses and match them with effective therapies. Additionally, Pear Bio characterizes excess tissue to identify new therapeutic targets, addressing high unmet needs in cancer treatment. With a strong emphasis on personalized testing and drug discovery, Pear Bio is positioned to make significant advancements in precision medicine for oncology.
Something looks off?On-site & Remote